• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

螯合剂对铁蛋白中铁的动员作用。

Iron mobilization from ferritin by chelating agents.

作者信息

Crichton R R, Roman F, Roland F

出版信息

J Inorg Biochem. 1980 Dec;13(4):305-16. doi: 10.1016/s0162-0134(00)80251-2.

DOI:10.1016/s0162-0134(00)80251-2
PMID:7193239
Abstract

The release of iron from horse spleen ferritin by the chelating agents desferrioxamine B, rhodotorulic acid, 2,3-dihydroxybenzoate, 2,2'-bipyridyl and pyridine-2-aldehyde-2-pyridyl hydrazone (Paphy) has been studied in vitro. Ferritin prepared by classical procedures involving thermal denaturation releases its iron less effectively than ferritin isolated by a modified procedure that avoids this step. Desferrioxamine B and rhodotorulic acid are the most effective in releasing iron from both preparations of ferritin. When FMN is added, iron release by desferrioxamine B, rhodotorulic acid, and 2,3-dihydroxybenzoate was effectively blocked, whereas both bipyridyl and Paphy showed a marked simulation. A substantial increase in iron release was also observed for bipyridyl and Paphy with ascorbate; a less important increase was noted for rhodotorulic acid. EDTA exerted a marked inhibition of iron release from ferritin with rhodotorulic acid, 2,3-dihydroxybenzoate, bipyridyl, and Paphy. The effects of citrate and oxalate on iron release by the chelators was small. The effect of the concentration of flavin on iron release from ferritin by bipyridyl and desferrioxamine B have been studied. Desferrioxamine is unable to mobilize FeII from ferritin following reduction by reduced FMN, whereas bipyridyl can rapidly complex the ferrous iron. The results are discussed in the context of our current concepts of storage iron mobilization in the treatment of iron overload.

摘要

已在体外研究了螯合剂去铁胺B、红酵母氨酸、2,3-二羟基苯甲酸盐、2,2'-联吡啶和吡啶-2-醛-2-吡啶腙(Paphy)从马脾铁蛋白中释放铁的情况。通过涉及热变性的经典程序制备的铁蛋白释放铁的效率低于通过避免这一步骤的改良程序分离的铁蛋白。去铁胺B和红酵母氨酸在从两种铁蛋白制剂中释放铁方面最有效。添加FMN时,去铁胺B、红酵母氨酸和2,3-二羟基苯甲酸盐引起的铁释放被有效阻断,而联吡啶和Paphy则表现出明显的促进作用。联吡啶和Paphy与抗坏血酸盐一起时,铁释放也显著增加;红酵母氨酸的增加不太明显。EDTA对红酵母氨酸、2,3-二羟基苯甲酸盐、联吡啶和Paphy引起的铁蛋白铁释放有明显抑制作用。柠檬酸盐和草酸盐对螯合剂铁释放的影响较小。研究了黄素浓度对联吡啶和去铁胺B从铁蛋白中释放铁的影响。去铁胺在被还原型FMN还原后无法从铁蛋白中动员亚铁,而联吡啶可以迅速络合亚铁。在我们目前关于治疗铁过载中储存铁动员概念的背景下讨论了这些结果。

相似文献

1
Iron mobilization from ferritin by chelating agents.螯合剂对铁蛋白中铁的动员作用。
J Inorg Biochem. 1980 Dec;13(4):305-16. doi: 10.1016/s0162-0134(00)80251-2.
2
The effect of chelating agents on cellular iron metabolism.
Clin Sci Mol Med. 1976 Mar;50(3):145-52. doi: 10.1042/cs0500145.
3
Effect of chaotropes on the kinetics of iron release from ferritin by flavin nucleotides.变溶剂对黄素核苷酸促进铁蛋白中铁释放动力学的影响。
Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3257-3262. doi: 10.1016/j.bbagen.2017.09.016. Epub 2017 Sep 21.
4
Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.去铁胺、红酵母酸和胆酰氧肟酸对培养的肝细胞中转铁蛋白和铁交换的影响。
Clin Physiol Biochem. 1985;3(6):277-88.
5
Mobilization of iron from ferritin by isolated mitochondria. Effects of species compatibility between ferritin and mitochondria and iron content of ferritin.
Biochim Biophys Acta. 1981 Sep 18;677(1):50-6. doi: 10.1016/0304-4165(81)90144-6.
6
2-Hydroxypyridine-N-oxides: effective new chelators in iron mobilisation.
Biochim Biophys Acta. 1987 Apr 16;924(1):13-8. doi: 10.1016/0304-4165(87)90065-1.
7
The release of iron from horse spleen ferritin by reduced flavins.还原型黄素促使马脾铁蛋白释放铁。
Biochem J. 1974 Nov;143(2):311-5. doi: 10.1042/bj1430311.
8
Rapid release of iron from ferritin by siderophores.
J Inorg Biochem. 1983 Apr;18(2):161-8. doi: 10.1016/0162-0134(83)80019-1.
9
Iron release from ferritin by flavin nucleotides.黄素核苷酸介导铁从铁蛋白的释放。
Biochim Biophys Acta. 2013 Oct;1830(10):4669-74. doi: 10.1016/j.bbagen.2013.05.031. Epub 2013 May 29.
10
Iron release from haemosiderin and ferritin by therapeutic and physiological chelators.治疗性螯合剂和生理性螯合剂从含铁血黄素和铁蛋白中释放铁。
Biochem J. 1989 Jun 15;260(3):903-7. doi: 10.1042/bj2600903.

引用本文的文献

1
New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.阿司匹林抗癌活性的新见解:其铁螯合抗氧化代谢产物的主要作用
Antioxidants (Basel). 2024 Dec 29;14(1):29. doi: 10.3390/antiox14010029.
2
The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites.阿司匹林与缺铁之谜:铁螯合代谢物的关键缺失环节。
Int J Mol Sci. 2024 May 9;25(10):5150. doi: 10.3390/ijms25105150.
3
Iron Release from Soybean Seed Ferritin Induced by Cinnamic Acid Derivatives.
肉桂酸衍生物诱导大豆种子铁蛋白释放铁
Pharmaceuticals (Basel). 2018 May 4;11(2):39. doi: 10.3390/ph11020039.
4
Multifunctional Polymeric Micelles for Combining Chelation and Detection of Iron in Living Cells.多功能聚合物胶束用于螯合和检测活细胞中的铁
Adv Healthc Mater. 2017 Sep;6(17). doi: 10.1002/adhm.201700162. Epub 2017 Jun 29.
5
Iron acquisition in Bacillus cereus: the roles of IlsA and bacillibactin in exogenous ferritin iron mobilization.蜡样芽胞杆菌中铁的获取: IlsA 和杆菌肽铁在外源铁蛋白铁动员中的作用。
PLoS Pathog. 2014 Feb 13;10(2):e1003935. doi: 10.1371/journal.ppat.1003935. eCollection 2014 Feb.
6
Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments.从铁蛋白中吸收铁不受血红素铁和亚铁盐的影响,这在女性和大鼠肠道段中是一致的。
J Nutr. 2012 Mar;142(3):478-83. doi: 10.3945/jn.111.145854. Epub 2012 Jan 18.
7
Ferritin contains less iron (59Fe) in cells when the protein pores are unfolded by mutation.当蛋白质孔因突变而展开时,细胞中的铁蛋白含有的铁(59Fe)较少。
J Biol Chem. 2008 Nov 14;283(46):31394-400. doi: 10.1074/jbc.M806025200. Epub 2008 Sep 19.
8
A risk-benefit assessment of iron-chelation therapy.铁螯合疗法的风险效益评估。
Drug Saf. 1997 Dec;17(6):407-21. doi: 10.2165/00002018-199717060-00006.
9
The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.心脏保护剂ICRF-187 [(+)-1,2-双(3,5-二氧代哌嗪基-1-基)丙烷]及其水解产物ADR-925对转铁蛋白、铁蛋白和铜蓝蛋白中金属离子的去除作用
Agents Actions. 1993 May;39(1-2):72-81. doi: 10.1007/BF01975717.
10
Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.去铁胺和ICRF-187对阿霉素诱导的自发性高血压大鼠毒性的保护作用比较。
Cancer Chemother Pharmacol. 1994;35(2):93-100. doi: 10.1007/BF00686629.